Brains Bioceutical
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Vancouver, British Columbia, CanadaPhone Number
(855) 927-2476Website
www.brainsbioceutical.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Brains Bioceutical
Brains Bio is the leader in evidence-based cannabinoid and phytochemical active pharmaceutical ingredients (API) to enhance life and treatment options for consumers and patients. Headquartered in Vancouver, Canada with operations in the United Kingdom , Brains Bio is one of the only producers of natural hemp-based cannabinoid APIs in the world. Combined with the company's unparalleled expertise and institutional knowledge in biotechnology, pharmaceuticals and cannabinoid-based product development, Brains Bio is strategically positioned to be a trailblazer in healthcare innovation across the world.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Brains Bioceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Brains Bioceutical has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Brains Bioceutical recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Brains Bioceutical is spiking on competitors!
Funding: Get notified immidiatlly once Brains Bioceutical has new funding data
Congratulate Masked Content for being promoted to Masked Content at Brains Bioceutical
Product Launch: Get notified when Brains Bioceutical launches new products
Brains Bioceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Brains Bioceutical had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Brains Bioceutical as Masked Content
Find 3 more new buyers
Compare Similar Companies to Brains Bioceutical
Compare insights from companies similar to Brains Bioceutical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Brains Bioceutical
<$5M
11-50
Private
$31.9M
2010
N/A
$15.4M
51-200
Private
-
1997
JH
Joshua HoernerExecutive Vice President & General Manager, Noramco Llc & Purisys, Llc
Company Profile Activity
Activity Insights
Brains Bioceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Brains Bioceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Brains Bioceutical.
Brains Bioceutical financials insights
Gather financial insights about Brains Bioceutical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$31.9M
Brains Bioceutical Tech Stack
A closer look at the technologies used by Brains Bioceutical
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Lateral Move
Executive Move
Funding
Funding
Brains Bioceutical News & Media
Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare
Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and 2024 $1.4 Billion Revenue Projection Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and 2024 $1.4 Billion Revenue ProjectionBrains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division
VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health Division. This enhancement is led by John Boshart, a distinguished figure in animal health with profound experience from his tenures at Pfizer Animal Health and Zoetis. His arrival signifies a strategic consolidation of talent and expertise aimed at redefining standards within the veterinary sector.Brains Bioceutical Corp, the Global Leader in Natural Cannabinoid APIs, Introduces Revolutionary Solid THC, Ushering in a New Era of Clinical Research
Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp's Solid THC Paves the Way for Revolutionary Drug Development for the pharmaceutical industry. Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp's Solid THC Paves the Way for Revolutionary Drug Development for the pharmaceutical industry.Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
Through its wholly owned subsidiary BSPG Laboratories, Brains Bio’s new facility is set to become a global research center for cannabinoid research, testing, and commercialization of natural EU GMP API’s Through its wholly owned subsidiary BSPG Laboratories, Brains Bio’s new facility is set to become a global research center for cannabinoid research, testing, and commercialization of natural EU GMP API’s
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Brains Bioceutical
Sign Up For FreeTo access detailed company insights
Brains Bio is the leader in evidence-based cannabinoid and phytochemical active pharmaceutical ingredients (API) to enhance life and treatment options for consumers and patients. Headquartered in Vancouver, Canada with operations in the United Kingdom , Brains Bio is one of the only producers of natural hemp-based cannabinoid APIs in the world. Com... Read More
